The serum levels of alanine aminotransferase, aspartate aminotransferase, prothrombin activity, albumin, and HBV DNA in patients with HBV-LC and those with HBV-PLC patients were significantly lower than in CHB patients (all P<0.05). The gene discussed is GPT; the disease is laryngotracheoesophageal cleft.